Today's Low
₹ 272.80
Today's High
₹ 279.65
52 Weeks Low
₹ 128.35
52 Weeks High
₹ 199.65
Lower
₹ 211.95
Upper
₹ 317.85
Par Drugs and Chemicals Limited develops, produces, and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, and amorphous and blended products. The company also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 43.6 | 41.2 | 24.2 | 14.2 | 14.1 | 13.6 | 14.6 | 12.8 | 13.7 | 9.5 | 8.6 |
Total Non-Current Assets | 35.1 | 35.2 | 35.9 | 37.1 | 39.8 | 42.5 | 43.4 | 45.8 | 47.7 | 43.2 | 20.2 |
Total Assets | 78.7 | 76.4 | 60.1 | 51.3 | 53.9 | 56.0 | 58.0 | 58.6 | 61.4 | 52.7 | 28.8 |
Total Current Liabilities | 14.9 | 16.0 | 10.8 | 12.5 | 17.0 | 19.6 | 22.0 | 19.0 | 18.3 | 11.7 | 5.7 |
Total Non-Current Liabilities | 4.0 | 8.2 | 8.7 | 9.8 | 15.9 | 17.3 | 18.7 | 22.6 | 26.9 | 25.5 | 8.5 |
Shareholder's Funds | 59.9 | 52.2 | 40.6 | 29.0 | 21.0 | 19.2 | 17.4 | 17.0 | 16.2 | 15.4 | 14.5 |
Total Liabilities | 78.7 | 76.4 | 60.1 | 51.3 | 53.9 | 56.0 | 58.0 | 58.6 | 61.4 | 52.7 | 28.8 |
The Industry Debt to Equity Ratio stands at 0.37, vs the Debt to Equity Ratio of 0.00, which results in a Positive aspect.
The Industry Quick Ratio stands at 1.41, vs the Quick Ratio of 3.15, which results in a Positive aspect.
The Industry Price to BV stands at 10.96, vs the Price to BV of 3.97, which results in a Negative aspect.
The Industry Current Ratio stands at 2.17, vs the Current Ratio of 3.53, which results in a Positive aspect.
Particulars | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 75.1 | 60.8 | 55.9 | 46.3 | 42.4 | 48.8 | 33.3 | 33.3 | 27.3 | 18.7 | 18.8 |
Total Expenditure | 58.8 | 44.7 | 46.4 | 38.1 | 34.4 | 40.3 | 26.1 | 25.8 | 19.9 | 15.6 | 15.5 |
Operating Profit(Excl OI) | 16.4 | 16.2 | 9.6 | 8.3 | 8.1 | 8.5 | 7.2 | 7.5 | 7.4 | 3.1 | 3.3 |
Add: Other Income | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Operating Profit | 16.4 | 16.2 | 9.6 | 8.3 | 8.1 | 8.5 | 7.2 | 7.5 | 7.4 | 3.1 | 3.3 |
Less: Interest | 0.5 | 0.6 | 0.8 | 2.0 | 2.3 | 2.5 | 3.6 | 4.0 | 4.0 | 0.8 | 0.8 |
PBDT | 16.0 | 15.6 | 8.8 | 6.3 | 5.7 | 6.0 | 3.7 | 3.6 | 3.4 | 2.3 | 2.5 |
Less: Depreciation Amortization | 3.3 | 2.8 | 2.8 | 3.0 | 3.1 | 2.8 | 2.7 | 2.3 | 2.2 | 0.9 | 0.8 |
PBT & Exceptional Items | 12.7 | 12.7 | 6.0 | 3.3 | 2.6 | 3.2 | 1.0 | 1.2 | 1.2 | 1.3 | 1.7 |
Less: Exceptional Income Expenses | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 12.7 | 14.7 | 6.0 | 3.3 | 2.6 | 3.2 | 1.0 | 1.2 | 1.2 | 1.3 | 1.7 |
Less: Taxation | 3.5 | 3.1 | 1.2 | 0.8 | 1.1 | 1.3 | 0.6 | 0.3 | 0.5 | 0.4 | 0.6 |
Profit After Tax | 9.2 | 11.6 | 4.8 | 2.5 | 1.5 | 1.9 | 0.4 | 0.9 | 0.7 | 0.9 | 1.1 |
Earnings Per Share | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry PAT Margin stands at 13.11, vs the PAT Margin of 10.46, which results in a Negative aspect.
The Industry PAT Growth stands at 33.11, vs the PAT Growth of 23.02, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.41, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PE Ratio stands at 61.34, vs the PE Ratio of 22.91, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 15.1 | 12.7 | 14.7 | 6.0 | 3.3 | 2.6 | 3.2 | 1.0 | 1.2 | 1.2 | 1.3 | 1.7 |
Tax Paid | -4.3 | -3.1 | -3.6 | -0.9 | -0.7 | -0.4 | -0.7 | 0.0 | -0.4 | -0.3 | -0.3 | -0.3 |
Adjustment | 3.0 | 3.5 | 1.3 | 3.4 | 4.3 | 5.0 | 5.2 | 6.1 | 6.1 | 6.0 | 1.7 | 1.2 |
Changes In Working Capital | 15.1 | 12.7 | 14.7 | 6.0 | 3.3 | 2.6 | 3.2 | 1.0 | 1.2 | 1.2 | 1.3 | 1.7 |
Cash Flow after changes in Working Capital | 17.6 | 10.7 | 15.7 | 8.5 | 4.1 | 5.0 | 9.9 | 6.6 | 9.3 | 5.6 | 3.3 | 1.6 |
Cash Flow from Operating Activities | 13.4 | 7.6 | 12.1 | 7.7 | 3.4 | 4.6 | 9.2 | 6.5 | 8.9 | 5.3 | 3.0 | 1.3 |
Cash Flow from Investing Activities | -7.3 | -3.0 | 0.1 | -1.5 | -0.3 | -0.6 | -1.7 | -0.2 | -0.3 | -6.2 | -24.0 | -7.2 |
Cash Flow from Financing Activities | 0.0 | -9.6 | 1.6 | 1.1 | -3.1 | -4.0 | -8.4 | -5.5 | -9.3 | 1.6 | 20.9 | 5.9 |
Net Cash Inflow / Outflow | 6.0 | -5.0 | 13.8 | 7.3 | 0.0 | 0.0 | -0.9 | 0.9 | -0.7 | 0.7 | -0.1 | 0.1 |
Opening Cash & Cash Equivalents | 16.2 | 21.2 | 7.4 | 0.0 | 0.1 | 0.0 | 0.9 | 0.0 | 0.7 | 0.0 | 0.1 | 0.0 |
Closing Cash & Cash Equivalent | 22.2 | 16.2 | 21.2 | 7.4 | 0.0 | 0.1 | 0.0 | 0.9 | 0.0 | 0.7 | 0.0 | 0.1 |
The Industry PCF RATIO stands at 2.34, vs the PCF RATIO of 12.88, which results in a Positive aspect.
The Industry PFCF Ratio stands at -108.25, vs the PFCF Ratio of 26.62, which results in a Positive aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 240.0 | 258.9 | 229.4 | 244.9 | 229.3 | 248.2 | 235.1 | 220.8 | 169.2 | 196.0 |
Total Income | 242.3 | 259.4 | 229.5 | 245.2 | 229.7 | 248.3 | 236.6 | 221.5 | 169.7 | 196.2 |
Total Expenditure | 187.7 | 185.3 | 188.0 | 191.1 | 197.0 | 189.1 | 198.2 | 175.6 | 133.6 | 155.5 |
PBIDT (Excl OI) | 52.3 | 73.6 | 41.3 | 53.8 | 32.3 | 59.0 | 36.9 | 45.2 | 35.6 | 40.5 |
Other Income | 2.3 | 0.5 | 0.1 | 0.3 | 0.4 | 0.2 | 1.5 | 0.7 | 0.5 | 0.3 |
Operating Profit | 54.6 | 74.1 | 41.5 | 54.2 | 32.7 | 59.2 | 38.4 | 45.9 | 36.1 | 40.7 |
Interest | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.5 | 0.9 | 1.0 | 2.3 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 54.4 | 73.8 | 41.3 | 53.9 | 32.4 | 58.9 | 38.0 | 45.0 | 35.1 | 38.4 |
Depreciation | 8.7 | 8.5 | 8.3 | 8.5 | 7.4 | 9.1 | 7.3 | 8.7 | 7.8 | 8.4 |
Profit Before Tax | 45.7 | 65.4 | 33.0 | 45.4 | 25.0 | 49.8 | 30.7 | 36.3 | 27.4 | 30.1 |
Tax | 11.5 | 16.5 | 8.3 | 10.9 | 6.3 | 12.5 | 7.7 | 12.0 | 6.2 | 7.9 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 34.2 | 48.9 | 24.7 | 34.5 | 18.7 | 37.2 | 22.9 | 24.2 | 21.1 | 22.2 |
Net Profit | 34.2 | 48.9 | 24.7 | 34.5 | 18.7 | 37.2 | 22.9 | 24.2 | 21.1 | 22.2 |
ADDITIONAL INFOS: | ||||||||||
Equity Capital | 123.1 | 123.1 | 123.1 | 123.1 | 123.1 | 123.1 | 123.1 | 123.1 | 123.1 | 123.1 |
Reserves | 697.2 | 662.9 | 614.0 | 589.3 | 554.6 | 535.9 | 498.7 | 475.7 | 451.6 | 445.9 |
EPS | 2.8 | 4.0 | 2.0 | 2.8 | 1.5 | 3.0 | 1.9 | 2.0 | 1.7 | 1.8 |
Operating Profit Margin | 22.7 | 28.6 | 18.1 | 22.1 | 14.3 | 23.9 | 16.3 | 20.8 | 21.3 | 20.8 |
Net Profit Margin | 14.3 | 18.9 | 10.8 | 14.1 | 8.1 | 15.0 | 9.8 | 11.0 | 12.5 | 11.3 |
The Industry Net Sales Growth stands at 28.21, vs the Net Sales Growth of 27.54, which results in a Negative aspect.
The Industry Mcap Growth stands at -5.10, vs the Mcap Growth of -12.36, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 298.20 | 318.06 | 274.06 |
R3 | 292.02 | 289.88 | 269.48 |
R2 | 285.83 | 284.76 | 267.95 |
R1 | 275.37 | 273.23 | 266.43 |
Pivot | 269.18 | 268.11 | 269.18 |
S1 | 258.72 | 256.58 | 263.37 |
S2 | 252.53 | 251.46 | 261.85 |
S3 | 242.07 | 239.93 | 260.32 |
S4 | 231.60 | 218.16 | 255.74 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
28.82
Neutral
RSI
67.34
Neutral
ROC
20.01
Bullish
UltimateOscillator
40.30
Neutral
Williams Indicator
-49.31
Neutral
CCI Indicator
104.85
Bearish
MACD
-2,737.67
Bearish
Stochastic Indicator
53.09
Neutral
ATR
19.85
High Volatility
Ex-Date | Ratio | Record Date |
---|---|---|
27-04-2021 | 1:1 | 28-04-2021 |
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
22-11-2021 | 1.25 | 12.5 | Interim |
Date Of Conduct | Board Meeting Details |
---|---|
07-03-2024 | Other business matters |
16-02-2024 | PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 16-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Other business. |
14-02-2024 | Financial Results/Other business matters |
28-10-2023 | PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Other business. |
17-08-2023 | PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-Aug-2023 to consider Other business. |
03-08-2023 | PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Other business. |
27-04-2023 | PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-Apr-2023 to consider financial statements for the period ended March 2023, Financial results/Other business. |
10-02-2023 | Financial Results/Other business matters |
09-11-2022 | Financial results/Other business matters |
28-07-2022 | Other business matters |
13-06-2022 | Other business matters |
07-05-2022 | Financial results/Other business matters |
07-02-2022 | Financial Results/Other business matters |
09-11-2021 | Financial Results/Dividend/Other business matters |
24-08-2021 | Other business matters |
10-06-2021 | Financial Results/Other business matters |
30-04-2021 | Bonus/Other business matters |